Ccm

Quick links to important sections

Ccm

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ccm

What is CCM? A Quick Overview

Property Description
Active ingredient Calcium Citrate Malate, Cholecalciferol (Vitamin D3), Folic Acid (Vitamin B9)
Form Film-coated tablets (Oral formulation)
Pharmacological class Nutritional Supplements; Calcium and Vitamin D Preparations
General purpose Support for bone health and correcting nutritional deficiencies
Origin Derived (Combination of a mineral salt and vitamins)

What is Calcium Citrate Malate (CCM) and Its Class?

The CCM preparation is defined as an oral formulation classified within the high-level pharmacological group of Nutritional Supplements, specifically as a combined Calcium Preparation and Vitamin D Preparation. It functions as a combination product designed for supporting long-term nutrient homeostasis. Typically supplied as a film-coated tablet, this preparation is distinguished by its use of Calcium Citrate Malate, a highly water-soluble mineral salt, making it an easily absorbed source of calcium when compared to less soluble forms. The combination of calcium and vitamin D is commonly recognized for its benefit in promoting overall bone health. This specific formulation is widely available as an over-the-counter (OTC) option, making it accessible for general adult and elderly nutritional management.


The Composition and General Purpose of the CCM Combination

CCM contains three primary active ingredients: Calcium Citrate Malate, Cholecalciferol (Vitamin D3), and Folic Acid (Vitamin B9). Calcium Citrate Malate provides the necessary Elemental Calcium for structural and metabolic functions. This specific complex is clinically recognized for its superior bioavailability compared to other calcium salts, which is a key distinguishing feature of this formulation. The simultaneous inclusion of Cholecalciferol is critical, as this vitamin is essential for the efficient intestinal absorption facilitation of calcium. Furthermore, Folic Acid supports core cellular functions. The overall general purpose of the CCM combination supplement is to provide foundational nutritional support by helping the body correct or maintain adequate levels of these critical nutrients, particularly during life stages such as pregnancy or post-menopause when nutritional demands are heightened.

What side effects are possible with Ccm?

Possible Side Effects and Safety Information

The official safety profile for the Calcium Citrate Malate (CCM) combination product focuses primarily on potential Metabolism and Nutrition Disorders and Gastrointestinal Disorders.

Adverse Reactions Classified by Frequency

Adverse reactions are classified according to official regulatory frequency terminology:

  • Uncommon (occurring in 1/1,000 to 1/100 people): May include hypercalcaemia (elevated blood calcium) and hypercalciuria (excessive urinary calcium excretion).
  • Rare (occurring in 1/10,000 to 1/1,000 people): Includes gastrointestinal disturbances such as constipation, flatulence, abdominal pain, nausea, and diarrhea. Skin reactions like pruritus (itching) and urticaria (hives) are also classified as rare.
  • Very Rare (occurring in fewer than 1/10,000 people): Milk-alkali syndrome is documented, typically associated with overdose.
  • Not Known (cannot be estimated from available data): Includes severe hypersensitivity reactions, such as angioedema (swelling beneath the skin).

Serious Safety Considerations

Serious adverse reactions documented in regulatory sources include severe manifestations of hypercalcaemia and, rarely, the Milk-alkali syndrome. Furthermore, the Folic Acid component may mask the haematological signs of Vitamin B12 deficiency, allowing potential neurological symptoms to advance undetected. Severe hypersensitivity (e.g., anaphylaxis) is a potential, though not commonly reported, serious reaction.

Population-Specific Constraints and Monitoring

The product is contraindicated in individuals with pre-existing conditions such as severe renal failure, hypercalcaemia, or nephrolithiasis (kidney stones). Caution and monitoring are required for patients with renal impairment or conditions like sarcoidosis. For patients on long-term treatment, regulatory documents advise monitoring of serum and urinary calcium levels and assessing kidney function to manage the risk of hypercalcaemia.

Overdose and Emergency Response

Overdose and When to Seek Help

Note: Chronic Care Management (Ccm) refers to a set of care services and is not a medication or substance with a chemical overdose profile. The context of “overdose” in relation to Ccm is based strictly on regulatory definitions for the high-risk patient population eligible for this coordinated care.

Official Regulatory Context of Overdose Risk

Classification Statement Derived from Official Documents
Population-Specific Risk Patients eligible for Ccm services have multiple (two or more) chronic conditions that place them at significant risk of death, acute exacerbation/decompensation, or functional decline. Overdose is cited as a significant risk in a subset of this high-risk population.
Emergency Management The Ccm program requires that care teams provide patient and caregiver access to a member of the care team 24 hours a day, 7 days a week to address urgent care needs and promote continuity of care.

When to Seek Immediate Medical Help

Official regulatory guidelines focus on identifying patients with pre-existing risks, including a high risk for drug overdose, who require the increased level of care coordination provided by Ccm. Any suspected or actual overdose event, given the vulnerable health status of the Ccm-eligible population, requires immediate access to emergency medical services. The 24/7 care access component of Ccm is intended to support the management of these urgent needs, but it does not replace calling emergency services for an active crisis like an overdose.

Therapeutic Uses of Ccm

The CCM preparation is commonly used to provide foundational nutritional support by addressing chronic shortfalls of its active components. Getting enough calcium and vitamin D in your diet supports the maintenance of bone strength and may assist with managing the risk of developing osteoporosis.

The supplement is considered relevant for addressing deficiencies in Calcium, Vitamin D, and Folic Acid, and may be part of symptomatic management for conditions like Osteopenia and the risk of fragility fractures. It is applied in contexts where additional symptomatic support is needed, frequently during life stages that create a heightened demand for these nutrients, such as in post-menopausal women and during pregnancy and lactation. By managing these systemic imbalances, the supplement contributes to easing the overall symptom load during symptomatic phases.

Quick Fact: Support for Nutritional Gaps and Bone Structure CCM may assist with managing symptoms related to increased neurological or muscular activity, such as certain muscle spasms associated with low calcium status, and general systemic fatigue associated with folate status.

Regulatory References

  1. Calcium, vitamin D, and your bones: MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Regulatory labeling establishes clear criteria for the use of the Calcium Citrate Malate (CCM) combination product, primarily focusing on a patient's mineral status and organ function.

Populations for whom use is Contraindicated:

  • Hypersensitivity: Patients with known allergy to the active ingredients or excipients must not use the medicine.
  • Metabolic Status: Absolute contraindications include pre-existing Hypercalcaemia (high blood calcium) and Hypervitaminosis D (toxic levels of Vitamin D).
  • Renal Conditions: Use is prohibited in patients with Severe Renal Impairment, Nephrolithiasis (kidney stones), or Hypercalciuria (high calcium in the urine).
  • Comorbidities: The product is contraindicated in patients with Pernicious Anemia due to the Folic Acid component.

Age- and Condition-Based Restrictions:

  • Adults and the Elderly are generally established for use, including Post-menopausal women.
  • Pediatric Use: Specific formulations are not recommended for children under 12 years of age.
  • Conditional Use: Patients with any degree of Renal Impairment or conditions like Sarcoidosis require specific monitoring of blood mineral levels due to altered metabolism.

What should I know about interactions with other medicines?

CCM Interactions with Other Medicines and Products

The interaction profile of this supplement, which contains Calcium Citrate Malate, Cholecalciferol (Vitamin D3), and Folic Acid, is primarily determined by its calcium content. Regulatory documents focus on two main types of interactions: reduced absorption of co-administered drugs and altered systemic calcium levels.

Interactions Requiring Timing Separation

To mitigate the reduced absorption of co-administered medicines, regulatory guidance advises separating the intake of CCM from several key drugs. This includes separating CCM intake from:

  • Tetracycline and Quinolone antibiotics (e.g., Ciprofloxacin, Doxycycline).
  • Levothyroxine (thyroid hormone replacement).
  • Bisphosphonates and Sodium Fluoride.
  • Dolutegravir (antiretroviral).

Pharmacodynamic and Metabolic Interactions

Official labeling identifies interactions that impact calcium or Vitamin D status:

Interacting Substance/Class Official Constraint
Thiazide Diuretics May increase the risk of hypercalcemia; requires calcium level monitoring.
Cardiac Glycosides (e.g., Digoxin) Requires cautious use due to potential increased cardiotoxicity.
Phenytoin and Barbiturates May increase Vitamin D metabolism, potentially reducing its effect.
Systemic Corticosteroids Can reduce calcium absorption; dose may need adjustment consideration.

Food and Population Notes

Official information notes that foods containing Oxalic Acid (e.g., spinach) or Phytic Acid (e.g., whole cereals) can inhibit calcium absorption. Additionally, specific caution and monitoring of calcium levels are advised for patients with renal impairment or conditions like Sarcoidosis.

Mechanism of Action

CCM (Cardiac Contractility Modulation) is a non-excitatory electrical therapy that precisely modulates key proteins within heart muscle cells to influence their contractile mechanics.

Cellular Modulation and Calcium Dynamics

The CCM signal is delivered during the absolute refractory period, preventing a new contraction. This targeted signal modulates the function of intracellular calcium-handling proteins, specifically SERCA2a and Phospholamban, inside the heart muscle cells. This interaction alters the storage and release kinetics of calcium, increasing the amount of calcium stored and released during each subsequent heartbeat.

Myocardial Force and Efficiency

The increased calcium released allows for a greater force of interaction between the contractile filaments (actin and myosin), leading directly to an increase in contractile force (inotropy). The non-excitatory timing of the signal prevents an increase in the heart muscle's oxygen consumption, resulting in higher contractile efficiency. Sustained modulation also alters the gene expression profile within the myocardium, promoting structural and functional changes that modify myocardial mechanics over time.

Dosage and Administration Information

How to Use CCM: Official Administration Guidelines

This section outlines the standardized usage patterns for the CCM combination (Calcium Citrate Malate, Cholecalciferol, Folic Acid).


Administration Route and Standard Dosing

The approved route for this preparation is exclusively oral use, typically administered as a film-coated tablet. The adult regimen specifies the use of two tablets per dose, administered on a twice daily schedule, ensuring the daily intake is divided for optimal systemic delivery.

For pediatric patients, the administration is set at a total of two tablets per day, which may be given in one or two divided doses. The overall duration of use is not fixed but is dependent on the individual's response to therapy and the continued need for nutritional correction, making it a potentially long-term usage pattern.


Contextual Constraints on Administration

Official instructions stipulate that the oral intake of CCM must be separated in time from certain other medications to avoid potential interference with absorption. These time-based constraints, which are part of proper use, include:

  • One Hour Before: CCM must be administered at least one hour before taking bisphosphonates.
  • Two Hours Before or After: A gap of at least two hours must be maintained before or after the intake of mineral preparations such as iron, zinc, or strontium ranelate.
  • Three Hours Before: Administration should occur at least three hours before the ingestion of sodium fluoride.

Population-specific usage notes, such as the requirement for caution and monitoring in patients with renal impairment, are integral to the official administration protocol.

Recent Clinical Evidence

Evidence for Use in Bone Health and Fracture Risk

Research into the components of the Ccm preparation was studied for the study of deficiencies related to bone health and conditions like osteoporosis. This research primarily relies on Randomized Controlled Trials (RCTs), which compare the nutrients to a placebo or to other nutrient forms. These trials, along with large-scale meta-analyses, have been applied in studies examining Bone Mineral Density (BMD), a key measure of bone strength. Findings related to bone density measurements indicated that research describes patterns related to BMD measurements in the observed populations, particularly postmenopausal women and older adults. However, the data show patterns related to inconsistent findings when examining fracture incidence across community-dwelling adults.


Research on Nutritional Study Outcomes

The Ccm preparation was evaluated in research exploring its use for the study of deficiencies during life stages that present a heightened demand for these nutrients. Pharmacokinetic findings indicate that the calcium form in Ccm data show patterns related to higher bioavailability when compared with certain other calcium salts. Research highlights changes measured during the study period, reporting measurements of serum biomarker levels in groups such as pregnant and lactating women. These studies help show what has been observed so far in specific populations.


What Remains Uncertain About Ccm Evidence

The research landscape highlights areas where certainty remains low or where additional studies are still needed. A major limitation is the inconsistency in findings related to the prevention of all fragility fractures. Also, the heterogeneity of study design means that comparative evidence is lacking for certain study methods. While studies explored long-term responses over defined time intervals, long-term effects are not fully established, and there is limited information for long-term outcomes specific to the tri-component combination of Calcium Citrate Malate, Vitamin D3, and Folic Acid. The results apply only to the populations studied, and evidence quality varies across studies.

Key Studies & References

  1. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults (USPSTF Draft Recommendation)
  2. Calcium and calcium supplements: Achieving the right balance (Mayo Clinic)

Frequently Asked Questions (FAQ)

Common questions about Ccm (FAQ)

Q: Is it possible to become dependent on Ccm?

According to official product information, CCM is classified as an over-the-counter nutritional supplement containing minerals and vitamins. Dependence or addiction is not cited in regulatory documents as a known risk associated with its use.


Q: What happens if I forget to take Ccm?

Guidance on a missed dose regimen typically suggests that if a dose is forgotten, it can be taken when remembered. If it is close to the next scheduled dose, regulatory information generally indicates skipping the missed dose and avoiding doubling up.


Q: Does Ccm cause weight gain or weight loss?

Weight changes are not listed as common side effects of CCM. However, unusual weight loss can be a potential serious sign of very high calcium levels in the blood (hypercalcaemia). This symptom is a sign that requires review by a healthcare professional.


Q: Can Ccm affect my ability to drive or operate machinery?

CCM is not typically associated with impairment. Nonetheless, official documents note that symptoms of overdose or high calcium levels (hypercalcaemia) may include confusion or drowsiness. If these symptoms are experienced, official sources indicate that driving or operating machinery may be compromised.


Q: Does Ccm interact with common pain relievers like ibuprofen?

Regulatory guidance on the Folic Acid component recommends that patients discuss the use of NSAIDs (Non-Steroidal Anti-inflammatory Drugs), such as ibuprofen, with their healthcare provider. This is relevant, especially when Folic Acid is used to address underlying deficiencies or medical conditions.


Q: What should I do if Ccm doesn't seem to be working?

The duration of CCM use is dependent on a patient's response to therapy and continued need for nutritional correction. If there are concerns about the expected efficacy, official guidance indicates that an evaluation by a healthcare provider may be required.


Q: How does Ccm affect blood pressure?

The product itself does not have a primary warning regarding blood pressure. However, research on the Folic Acid component of CCM has explored its role in supporting the management of hypertension (high blood pressure). It is important for patients to provide their healthcare provider with a complete list of all medications and supplements.


Q: Why do some people experience initial drowsiness when starting Ccm?

Drowsiness is not listed in official sources as a common side effect when starting CCM. However, it has been noted as a potential symptom of a very high blood calcium level (hypercalcaemia) or overdose. This symptom is a sign that requires review by a healthcare professional.


Q: Is Ccm known to cause hair loss?

Official regulatory documents do not list hair loss as a known or common side effect associated with the use of CCM (Calcium Citrate Malate, Cholecalciferol, Folic Acid).


Q: Are there any known interactions between Ccm and herbal remedies?

Official information notes that Folic Acid can interfere with certain mineral supplements, such as zinc. It is important for patients to inform their healthcare provider about all supplements and herbal remedies being used, as this allows for a review of potential interactions.


Q: Can Ccm affect my mood or behavior?

While not a common effect, mental/mood changes and confusion are listed in safety warnings as serious symptoms that may occur in cases of very high calcium levels (hypercalcaemia). These changes are serious symptoms that necessitate immediate review by a healthcare professional.


Q: Can I drink alcohol while taking Ccm, according to official warnings?

Regulatory sources generally advise avoiding or limiting the use of alcohol and caffeine. This advice is given to help decrease the risk of bone disease and optimize the conditions for calcium absorption.


Q: Does Ccm need to be taken with food?

The Calcium Citrate Malate form in CCM may be taken with or without food. Taking it with a meal, however, may help reduce or prevent potential gastrointestinal side effects, such as nausea.


Q: Is Ccm known to affect blood sugar levels?

Official product information notes that specific forms of the supplement (like chewable tablets) may contain sugar or aspartame. Patients with diabetes are advised to review the product information with a healthcare provider to ensure safe use and proper metabolic monitoring.


Q: Does Ccm have a black box warning in the US?

As an over-the-counter nutritional supplement containing only vitamins and minerals, CCM is not typically subject to the Black Box Warning (BBW) requirements. These warnings are generally reserved for prescription drugs with serious, life-threatening safety concerns.


Q: Can Ccm cause changes in vision?

Changes in vision are not listed in official regulatory documents as a known or common side effect associated with the use of this combination supplement.


Q: Is there a generic version of Ccm available?

Yes, the ingredients in CCM (Calcium Citrate Malate, Vitamin D3, Folic Acid) are widely available in generic or store-brand combination supplements as over-the-counter options.


Q: What are the most common safety concerns reported for Ccm?

The most common safety concerns reported for calcium citrate supplements are mild gastrointestinal issues. These typically include constipation, gas, and bloating. These effects are often milder than those caused by other forms of calcium.


Q: What does official guidance say about Ccm and pregnancy?

CCM contains Folic Acid, which is widely recommended by health authorities to be taken daily before and during early pregnancy to help prevent neural tube defects. The product may be used during pregnancy when clearly needed to address nutritional deficiencies.


Q: What does official guidance say about Ccm and breastfeeding?

The ingredients in CCM, including Folic Acid, are known to pass into breast milk. Folic acid and the other components are generally considered safe for use during breastfeeding within the recommended daily amounts.


Q: How is the dose of Ccm typically determined by a healthcare provider?

The dosage is determined by a healthcare provider based on the specific medical problem, the severity of any existing deficiency, and the individual’s overall dietary intake of calcium and vitamins. This ensures the correct amount for nutritional needs is provided.


Q: Can Ccm be taken with supplements or vitamins?

Official guidance often recommends that patients review the use of any other supplements or vitamins with their healthcare provider. This is mainly to avoid exceeding the recommended daily amounts and to prevent potential interactions, such as those with certain mineral supplements or antacids.


Q: Are there specific symptoms that require me to stop taking Ccm immediately?

Yes, official warnings describe specific symptoms that are signs of a serious reaction, such as a severe allergic reaction (rash, swelling, trouble breathing) or symptoms of high calcium levels (increased thirst, unusual weakness, vomiting, confusion). These signs require immediate review by a healthcare professional.


Q: Are there specific times of day that Ccm is typically taken?

CCM is typically taken at the same time(s) each day for consistency in systemic delivery. Some official notes suggest it may be taken before bedtime to minimize certain gastrointestinal side effects, like nausea.

How should Ccm be stored and disposed of?

How to Store and Dispose of CCM

The storage and disposal of CCM (Calcium Citrate Malate, Cholecalciferol, Folic Acid) tablets must adhere to regulatory labeling to maintain quality and safety.

Required Storage Conditions

Detail Regulatory Requirement
Temperature Store at controlled room temperature (typically below 25°C or 30°C).
Protection Protect from moisture and light; store in the original container and keep it tightly closed.
Safety Keep out of the sight and reach of children to prevent accidental ingestion.
Prohibited Do not freeze the tablets.

Official Disposal Instructions

Unused or expired CCM should be disposed of through an official drug take-back program. If a program is unavailable, mix the uncrushed tablets with an undesirable substance (e.g., dirt, coffee grounds), seal the mixture in a container, and discard it in household trash. Do not flush the tablets down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ccm found in:

A-Z Index: